Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend

Chiron Real Estate Inc.

2025-FY EPS reported -$0.91 revenue$148,208,000

Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).
Q4 Core FFO $1.16/sh, up 6.4% YoY; same-property Cash NOI growth 5.4% YoY.
Full year 2026 Core FFO guidance $4.30-$4.45 per share; no debt maturities in 2026/27.
Dividend switched from quarterly to monthly at $0.25/sh ($3.00 annualized, unchanged); White Rock Medical tenant filed Chapter 11.
Completed $51.3M Series B preferred offering; company renamed from Global Medical REIT to Chiron (XRN).

item 2.02item 5.03item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.